Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.62 |
| ▸ | CD69 | Q07108 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 7/20 | 0.53 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | POLB | P06746 | 4/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31700912 | 0.96 | TRPA1 (0.67) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL31702327 | 0.90 | TRPA1 (0.64) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL31702246 | 0.83 | TRPA1 (0.86) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL3364649 | 0.83 | TRPA1 (0.86) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL70162 | 0.83 | TRPA1 (0.86) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL70163 | 0.83 | TRPA1 (0.86) | TRPA1CD69KMT2AMEN1NPC1 | |
| Terephthalic Acid SCHEMBL2846917 | 0.83 | TSHR (0.67) | KMT2AMEN1POLBMAPTKDM4E | |
| SCHEMBL28611366 | 0.81 | TRPA1 (0.82) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL29163841 | 0.81 | TRPA1 (0.82) | TRPA1CD69KMT2AMEN1NPC1 | |
| SCHEMBL28018294 | 0.81 | TRPA1 (0.82) | TRPA1CD69KMT2AMEN1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320236-A1 | METAL ORGANIC FRAMEWORKS (MOFs) AND METHODS OF USE | CONWAY DAVID JONATHAN (US) | 2025-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250320236-A1 | METAL ORGANIC FRAMEWORKS (MOFs) AND METHODS OF USE | OGFOD1, OCIAD1, MLYCD | TRPA1 234/4885CD69 1392/4885KMT2A 1299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.